(VIANEWS) – HAFNIA LIMITED (HAFNI.OL), NAVAMEDIC (NAVA.OL), MONTEA (MONT.BR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. HAFNIA LIMITED (HAFNI.OL)
163.7% sales growth and 48.16% return on equity
Hafnia Limited owns and operates oil product tankers. The company operates through four segments: Long Range II (LR2), Long Range I (LR1), Medium Range (MR), and Handy size (Handy). It transports petroleum oil products, vegetable oil, and easy chemicals to national and international oil companies, and chemical companies, as well as trading and utility companies. The company provides ship owning, ship-management, chartering, investment, and agency office services. As of March 29, 2022, it operated a fleet of 237 vessels, including newbuilds, of which 145 are owned or chartered-in, including 10 owned LR2s, 40 owned and chartered-in LR1s, 58 owned and chartered-in MRs, and 29 owned Handy and eight stainless steel 25K vessels. The company is based in Hamilton, Bermuda. Hafnia Limited is a subsidiary of BW Group Limited.
Earnings Per Share
As for profitability, HAFNIA LIMITED has a trailing twelve months EPS of kr9.22.
PE Ratio
HAFNIA LIMITED has a trailing twelve months price to earnings ratio of 6.53. Meaning, the purchaser of the share is investing kr6.53 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.16%.
Sales Growth
HAFNIA LIMITED’s sales growth is 324.1% for the current quarter and 163.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 135.4%, now sitting on 1.83B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 3, 2023, the estimated forward annual dividend rate is 13.16 and the estimated forward annual dividend yield is 20.59%.
2. NAVAMEDIC (NAVA.OL)
72.2% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr0.47.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 85.11. Meaning, the purchaser of the share is investing kr85.11 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr40.00 at 16:20 EST, under its 52-week high of kr42.00 and way above its 52-week low of kr25.00.
3. MONTEA (MONT.BR)
25.8% sales growth and 17.64% return on equity
Montea is a developing investor in logistics real estate in Belgium, France, Germany and the Netherlands. Our team of passionate specialists creates the ideal real estate solution together with the customer.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €9.74.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 7.8. Meaning, the purchaser of the share is investing €7.8 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.64%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 20, 2022, the estimated forward annual dividend rate is 3.03 and the estimated forward annual dividend yield is 3.9%.
Sales Growth
MONTEA’s sales growth is 5% for the current quarter and 25.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.3%, now sitting on 111.01M for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MONTEA’s EBITDA is 26.6.
4. ASML HOLDING (ASML.AS)
17.9% sales growth and 59.35% return on equity
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to assess the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and lithography process and control software solutions; and refurbishes and upgrades older lithography systems, as well as offers customer support and associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Earnings Per Share
As for profitability, ASML HOLDING has a trailing twelve months EPS of €13.88.
PE Ratio
ASML HOLDING has a trailing twelve months price to earnings ratio of 43.26. Meaning, the purchaser of the share is investing €43.26 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 59.35%.
Volume
Today’s last reported volume for ASML HOLDING is 452998 which is 33.9% below its average volume of 685419.
Sales Growth
ASML HOLDING’s sales growth is 78% for the present quarter and 17.9% for the next.
5. PRODWAYS (PWG.PA)
15.4% sales growth and 6.68% return on equity
Prodways Group SA manufactures and sells industrial and professional 3D printers in France and internationally. The company operates in two segments, Systems and Products. It offers machines, such as 3D printing systems that include lost wax, DLP15resin, and laser sintering; and other related premium materials and services, as well as offers 3D design, simulation, and optimization software. The company also provides metal and plastic parts; orthopedic insoles for podiatry application; orthodontic pieces and dental trays, mouthpieces dental application; and hearing aid tips and custom hearing protection products for audiology application. It serves aerospace and defence, healthcare, automotive, consumer goods, and jewellery sectors. Prodways Group SA was founded in 2013 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PRODWAYS has a trailing twelve months EPS of €0.08.
PE Ratio
PRODWAYS has a trailing twelve months price to earnings ratio of 31.75. Meaning, the purchaser of the share is investing €31.75 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.68%.
